• National Survey Seeks to Assess Full Social, Economic Burdens of Rare Diseases in US
  • Diagnostic Delays in ALS ‘Surprisingly Large’ and Need Not Be, Study Says
  • Making Mental Notes While He’s Still Here
  • QurAlis Licenses Eli Lilly’s Preclinical Compounds That Target Neuronal Excitotoxicity
  • Eye-tracking Device Gives Voice to ALS Ice Bucket Challenge Co-founder Pat Quinn
  • Study Examines Barriers to Social Prescribing for People With Motor Neurone Disease
  • 200 ALS Patients Finish Dosing in Phase 3 Trial of NurOwn Cell Therapy
  • Learning How to Help from 5 Phone Calls
  • Severe Weight Loss Linked to Higher Risk of Death in Study of Patients
  • ‘Bar Code’ Identifies Nervous System Cells That May Be Key to Treating ALS
  • My Cuisine Adventures While Living with ALS
  • Compound Found in Blackberries Prolongs Lifespan, Reduces Disease Severity in ALS Mice